Dom-Titan Dd logo

TIKG - Dom-Titan Dd News Story

€6 0.0  0.0%

Last Trade - 21/08/17

Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 645

Slovenian Unior gets 112.8 mln euro syndicated loan

Mon 19th December, 2016 1:05pm
LJUBLJANA, Dec 19 (Reuters) - Slovenian metal products maker 
Unior  UKIG.LJ , which is due to be privatised, has received a 
loan of 112.8 million euros ($118 million) from a syndicate of 
banks, the company said on Monday. 
    "With the syndicated loan we repaid old loans, reduced the 
number of bank creditors ... improved conditions and opened a 
possibility for further growth of the company," Unior's CEO 
Darko Hrastnik said in a statement. 
    Shares in Unior, which has market capitalisation of about 50 
million euros, jumped 7.5 percent to 18.8 euros by 1245 GMT, 
outperforming the blue-chip SBI index  .SBITOP  which was 1 
percent lower. 
    The loan was organised by Slovenia's largest lender, 
state-owned Nova Ljubljanska Banka (NLB). 
    The five other banks in the syndicate were Slovenia's Abanka 
and Gorenjska banka, Nova KBM, which is owned by U.S. investment 
firm Apollo Global Management  APO.N , and local subsidiaries of 
Italy's Intesa Sanpaolo  ISP.MI  and Russia's Sberbank 
    Unior, which has almost 4,000 employees, exports 95 percent 
of its metal products, mainly to car factories. It also has a 
tourism division which accounts for 13 percent of its revenue. 
    Slovenian Sovereign Holding (SDH), a state-owned firm that 
is coordinating privatisations in the country, agreed with three 
other mostly state-owned firms in May to put their joint of 55 
percent stake in Unior on sale.*:nL5N1864RL 
    Unior is one of at least five companies Slovenia wants to 
privatise next year with NLB the biggest on the list. 
   ($1 = 0.9582 euros) 
 (Reporting by Marja Novak; editing by David Clarke) 
 ((; +386-1-5058805; Reuters 
Keywords: UNIOR LOAN/
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.